Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Form SC 13D/A Dragonfly Energy Holding Filed by: Chardan NexTech Investments 2 LLC
-
4D Molecular Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Insignia Systems, Inc. Announces First Quarter 2023 Financial Results
-
Dragonfly Energy (DFLI) and Ioneer (IONR) Sign Lithium Supply Agreement
-
Dragonfly Energy and Ioneer Sign Lithium Supply Agreement
-
4D Molecular Therapeutics Inc. (FDMT) Prices Upsized 7.5M Share Offering at $16/sh
-
4D Molecular Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
-
4D Molecular Therapeutics Inc. (FDMT) Announces Proposed $100M Share Offering
-
4D Molecular Therapeutics Announces Proposed Public Offering of Common Stock
-
SunPower Invests in Wolf River Electric, Expanding Solar Footprint in the Midwest
-
Iovance Biotherapeutics to Present at Upcoming Conferences
-
Iovance Biotherapeutics to Present at Upcoming Conferences
-
Gardiner Healthcare Acquisitions Corp. Announces Extension
-
Tenaya Therapeutics to Participate at Chardan's 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
-
TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Differentiated with Focus on Tech-Driven Solutions, Outstanding Customer Service
-
Solid Biosciences to Participate in Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
-
MeiraGTx to Participate in Upcoming Investor Conferences
-
MeiraGTx to Participate in Upcoming Investor Conferences
-
Vor Bio to Participate in Upcoming Investor Conferences
-
Dragonfly Energy Holdings (DFLI) and Airstream Announce Battery Partnership
-
Dragonfly Energy and Airstream Announce Battery Partnership
-
Dragonfly Energy and Airstream Announce Battery Partnership
-
REGENXBIO Announces Presentation at Chardan's 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
-
Sensorion to participate in Chardan’s Annual Genetic Medicines & Cell Therapy Manufacturing Summit and Kempen’s Life Sciences Conference
-
Dragonfly Energy Files Annual Report on Form 10-K and Updates Operating Results for the Fourth Quarter and Year ended December 31, 2022
-
Dragonfly Energy Files Annual Report on Form 10-K and Updates Operating Results for the Fourth Quarter and Year ended December 31, 2022
-
Achilles Therapeutics to Present at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
-
Achilles Therapeutics to Present at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
-
Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
-
Century Therapeutics to Present at Chardan’s 7th Annual Genetic Medicines & Cell Therapy Manufacturing Virtual Summit
-
Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
-
Century Therapeutics to Present at Chardan’s 7th Annual Genetic Medicines & Cell Therapy Manufacturing Virtual Summit
-
Senti Bio to Participate in Upcoming Investor Conferences
-
Senti Bio to Participate in Upcoming Investor Conferences
-
Form 3 Monterey Innovation Acqu For: Sep 29 Filed by: Chardan Monterey Investments LLC
-
Form 4 Monterey Innovation Acqu For: Mar 09 Filed by: Chardan Monterey Investments LLC
-
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Form X-17A-5 CHARDAN CAPITAL MARKETS For: Dec 31
-
Carisma Therapeutics to Present at Upcoming Healthcare Industry and Investor Conferences in April 2023
-
Better Therapeutics Announces $6.5MM Private Placement
-
Dragonfly Energy Reports Fourth Quarter and Full Year 2022 Financial Results
-
Dragonfly Energy Reports Fourth Quarter and Full Year 2022 Financial Results
-
Market Analysis Endorsement Boosts Prospects of OTR Shipping Optimizer Freight Technologies Inc. (NASDAQ: FRGT)
-
Gardiner Healthcare Acquisitions Corp. Announces Extension
-
Zura Bio Limited Announces Closing of Business Combination with JATT Acquisition Corp
-
8X Upside Projected for Freight Technologies, Inc. (NASDAQ: FRGT)
-
Bellevue Life Sciences Acquisition Corp. Announces Separate Trading of its Shares of Common Stock, Warrants and Rights Commencing March 17, 2023
-
Monterey Bio Acquisition Corp. Announces Rebrand and Management Changes
-
ZeroNox to Become First Public Company of its Kind, Through Merger with The Growth for Good Acquisition Corporation (GFGD)
-
ZeroNox, a Leader in Off-Highway Electrification of Commercial and Industrial Vehicles, to Become First Public Company of its Kind, Through Merger with The Growth for Good Acquisition Corporation

